recovery
Recovery & sleep
Reported anecdotally for sleep depth and overnight recovery markers. Largely preclinical mechanism.
Outcomes this condition tracks
Why certain peptides surface — weighted by clinical relevance.
Sleep quality
weight 1.00Primary anecdotal signal: sleep depth and latency.
Recovery time
weight 0.80Overnight recovery markers co-travel with sleep quality.
Mood regulation
weight 0.30Secondary downstream mood benefit of restored sleep.
Evidence matrix
Outcome × ingredient signal — backed by indexed studies.
Each cell shows the clinical signal status and the count of indexed studies for that ingredient × outcome pair. Click any cell to open the ingredient brief.
04Canonical, evidence-anchored
Matched protocol templates for this condition.
Matching templates…
Reported substances
What cohorts have used — and at what tier of evidence.
- IpamorelinGrowth hormone secretagogue200–300 mcg, 1–3× dailyAnecdotal→
- GHK-CuCopper-binding tripeptide1–2 mg/day (anecdotal, injectable)Anecdotal→
- CJC-1295 (with DAC)GHRH analogue (long-acting)1–2 mg/weekAnecdotal→
- SermorelinGHRH analogue100–500 mcg/nightHuman observational→
- DSIPNonapeptide (sleep modulator)100–500 mcg pre-sleepAnecdotal→
- EpitalonPineal tetrapeptide5–10 mg/day for 10–20 days, cyclicAnecdotal→
Suggestive, never prescriptive. Mydosage does not recommend a dose, a substance or a protocol. Decisions belong with you and a clinician.